InvestorsHub Logo
Followers 1
Posts 150
Boards Moderated 0
Alias Born 03/22/2009

Re: Whalatane post# 73595

Monday, 02/29/2016 10:49:41 PM

Monday, February 29, 2016 10:49:41 PM

Post# of 426531
Kiwi,

I don't see that as a challenge, I think you're agreeing with me.
The doc is completely in charge. The patient has no voice because the health risk and knowledge mis-match are both too high.

So the doc better be well informed and hopefully be willing to prescribe off label. It's obvious that with successful Reduce-It
that it will be prescribed to the Reduce-It population. But Fishy was saying that it would be malpractice not to prescribe it anyone on a statin. That's where I disagree.

Btw, I was referred to a cardiologist and he was reluctant at first to give me a prescription. I argued with confidence, got his respect, and he relented. But as I take a look at the patients in the waiting room at either the PCP or cardiologist it's obvious that 99% will never has any say.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News